AF
KRTX

Allworth Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Allworth Financial’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26
Closed -$8.23K – 3707
2023
Q4 		$8.23K Buy
26
+16
+160% +$3.11K ﹤0.01% 2060
2023
Q3 		$1.69K Buy
10
+1
+11% +$188 ﹤0.01% 2620
2023
Q2 		$1.95K Hold
9
– – ﹤0.01% 2496
2023
Q1 		$1.64K Sell
9
-1
-10% -$191 ﹤0.01% 2490
2022
Q4 		$1.97K Hold
10
– – ﹤0.01% 2251
2022
Q3 		$2K Buy
10
+9
+900% +$1.82K ﹤0.01% 2267
2022
Q2 		$0 Buy
+1
New +$115 ﹤0.01% 2923

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Allworth Financial's KRTX Position: Q1 2024 in Review

Allworth Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 26 shares — an estimated $8.23K sold.

Allworth Financial first reported a position in KRTX in Q2 2022 and held it in 7 quarters. The position peaked at $8.23K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Allworth Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allworth Financial sold 26 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $8.23K.
  • Allworth Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Allworth Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $8.23K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.